IKK-β links inflammation to obesity-induced insulin resistance
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation may underlie the metabolic disorders of insulin resistance and type 2 diabetes. IkappaB kinase beta (IKK-beta, encoded by Ikbkb) is a central coordinator of inflammatory responses through activation of NF-kappaB. To understand the role of IKK-beta in insulin resistance, we used mice lacking this enzyme in hepatocytes (Ikbkb(Deltahep)) or myeloid cells (Ikbkb(Deltamye)). Ikbkb(Deltahep) mice retain liver insulin responsiveness, but develop insulin resistance in muscle and fat in response to high fat diet, obesity or aging. In contrast, Ikbkb(Deltamye) mice retain global insulin sensitivity and are protected from insulin resistance. Thus, IKK-beta acts locally in liver and systemically in myeloid cells, where NF-kappaB activation induces inflammatory mediators that cause insulin resistance. These findings demonstrate the importance of liver cell IKK-beta in hepatic insulin resistance and the central role of myeloid cells in development of systemic insulin resistance. We suggest that inhibition of IKK-beta, especially in myeloid cells, may be used to treat insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“failure to effectively resolve inflammation leading to a chronic state of inflammation is associated with IR/T2D and obesity [79,143].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [143]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“The results showed that myeloid cell KO of IKKβ or JNK1 protected mice from HFD-induced glucose intolerance, hyperinsulinemia, and insulin resistance in skeletal muscle, adipose tissue, and the liver (24,87).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“to quantify these functions in two separate models: Ikbkb Δhep mice on HFD and Ikbkb Δhep mice rendered homozygous for the ob mutation, causing leptin deficienc”
MethodObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In addition, many of the genes upregulated within fat during obesity are expressed in macrophage”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Indeed, it was suggested that chronic inflammation contributes to obesity-induced insulin resistance through macrophage infiltration of fat depot”
BackgroundGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“, has increased considerably in recent years, reaching epidemic proportion”
BackgroundNuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Self-citationNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citationLocal and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Research works printed but not linked: 1
- Maeda, S. et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725–737 (2003). · DOI · Paper page
Cited by
Items 601–700 of 1,004
Ghrelin receptor regulates adipose tissue inflammation in aging
Lin, L., Lee, J. H., Buras, E. D., Yu, K., Wang, R., Smith, C. W., Wu, H., Sheikh‐Hamad, D., & Sun, Y. (2016) · Aging · doi:10.18632/aging.100888 · Cited by 89
Czauderna, C., Castven, D., Mahn, F. L., & Marquardt, J. U. (2019) · Cancers · doi:10.3390/cancers11081053 · Cited by 92
“Among the most prominent and well-characterized signaling pathways involved in the above described inflammation-fibrosis-cancer axis is the NF-κB pathway [10,11].”
BackgroundmiR-150 regulates obesity-associated insulin resistance by controlling B cell functions
Ying, W., Tseng, A. M., Chang, R. C.-A., Wang, H., Lin, Y., Kanameni, S., Brehm, T. J., Morin, A., Jones, B. T., Splawn, T. G., et al. (2016) · Scientific Reports · doi:10.1038/srep20176 · Cited by 87
Role of nuclear factor κB in liver health and disease
Robinson, S. M., & Mann, D. A. (2010) · Clinical Science · doi:10.1042/cs20090549 · Cited by 82
Kováčiková, M., Sengenès, C., Kováčová, Z., Šiklová, M., Klimčáková, E., Polak, J., Rossmeislová, L., Bajzová, M., Hejnová, J., Hnevkovska, Z., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.112 · Cited by 87
Krinninger, P., Ensenauer, R., Ehlers, K., Rauh, K., Stoll, J., Krauss-Etschmann, S., Hauner, H., & Laumen, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2611 · Cited by 82
Changes in Adipose Tissue Macrophages and T Cells During Aging
Garg, S. K., Delaney, C., Shi, H., & Yung, R. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006833 · Cited by 83
Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats
Hsiao, G., Chapman, J., Ofrecio, J. M., Wilkes, J., Resnik, J. L., Thapar, D., Subramaniam, S., & Sears, D. D. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2010 · Cited by 80
Chen, Y., Wu, Z., Zhao, S., & Xiang, R. (2016) · Scientific Reports · doi:10.1038/srep27486 · Cited by 80
Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice
Chiazza, F., Couturier-Maillard, A., Benetti, E., Mastrocola, R., Nigro, D., Cutrin, J. C., Serpe, L., Aragno, M., Fantozzi, R., Ryffel, B., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00104 · Cited by 80
RetractedKubota, T., Inoue, M., Kubota, N., Takamoto, I., Mineyama, T., Iwayama, K., Tokuyama, K., Moroi, M., Ueki, K., Yamauchi, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07358-9 · Cited by 86
From chronic overfeeding to hepatic injury: Role of endoplasmic reticulum stress and inflammation
Mollica, M. P., Lionetti, L., Putti, R., Cavaliere, G., Gaita, M., & Barletta, A. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.012 · Cited by 93
Redox-inflammatory synergy in the metabolic syndrome
Bryan, S., Baregzay, B., Spicer, D., Singal, P. K., & Khaper, N. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0295 · Cited by 80
“Indeed, ROS and ER stress can induce IKK to activate NF- B, stimulating expression of its many downstream pro-inflammatory cytokine gene targets (Arkan et al. 2005; Donath and Shoelson 2011).”
BackgroundLu, P., Yan, J., Liu, K., Garbacz, W. G., Wang, P., Xu, M., Ma, X., & Xie, W. (2015) · Hepatology · doi:10.1002/hep.27719 · Cited by 83
Liu, Z., & Cao, W. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582397 · Cited by 88
“IKK is a serine kinase that controls the activation of NF- B and links inflammation to insulin resistance [74, 80].”
BackgroundShinozaki, S., Choi, C. S., Shimizu, N., Yamada, M., Kim, M., Zhang, T., Shiota, G., Dong, H. H., Kim, Y.-B., & Kaneki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187666 · Cited by 90
Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
Fan, N., Sun, H., Wang, Y., Wang, Y., Zhang, L., Xia, Z., Peng, L., Hou, Y., Shen, W., Liu, R., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/752519 · Cited by 79
Rubio‐Aliaga, I., de Roos, B., Sailer, M., McLoughlin, G. A., Boekschoten, M. V., van Erk, M., Bachmair, E., van Schothorst, E. M., Keijer, J., Coort, S. L., et al. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00179.2010 · Cited by 85
“changes in the levels of inflammatory cytokines (2, 6, 51) and”
BackgroundInsights into the role of macrophage migration inhibitory factor in obesity and insulin resistance
Finucane, O. M., Reynolds, C. M., McGillicuddy, F. C., & Roche, H. M. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000730 · Cited by 94
Green, C. J., Macrae, K., Fogarty, S., Hardie, D. G., Sakamoto, K., & Hundal, H. S. (2011) · Biochemical Journal · doi:10.1042/bj20101517 · Cited by 78
The Role of Leukocytes in Diabetic Cardiomyopathy
Bajpai, A., & Tilley, D. G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01547 · Cited by 86
Liu, M.-J., Bao, S., Bolin, E. R., Burris, D. L., Xu, X., Sun, Q., Killilea, D. W., Shen, Q., Ziouzenkova, O., Belury, M. A., et al. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175158 · Cited by 88
Nicholls, H. T., Kowalski, G., Kennedy, D. J., Risis, S., Zaffino, L. A., Watson, N., Kanellakis, P., Watt, M. J., Bobik, A., Bonen, A., et al. (2011) · Diabetes · doi:10.2337/db10-1353 · Cited by 77
Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKβ
Nagashima, K., Sasseville, V. G., Wen, D., Bielecki, A., Yang, H., Simpson, C., Grant, E., Hepperle, M., Harriman, G., Jaffee, B., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3852 · Cited by 79
MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway
Huang, Z., Zheng, D., Pu, J., Dai, J., Zhang, Y., Zhang, W., & Wu, Z. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1569495 · Cited by 79
Circadian clock dysfunction in human omental fat links obesity to metabolic inflammation
Maury, E., Navez, B., & Brichard, S. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22571-9 · Cited by 83
Macrophages and T cells in metabolic disorder-associated cancers
Taranto, D., Kloosterman, D. J., & Akkari, L. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 86
“…and elicit their activation via pattern recognition receptors, such as nucleotide-binding oligomerization domain (NOD) or TLR signalling pathways, and lead to activation of nuclear factor-κB (NF-κB), promoting a pro-inflammatory cascade and contributing to systemic insulin resistance 36,53 .”
Angelakis, E., Bastelica, D., Amara, A. B., Filali, A. E., Dutour, A., Mège, J., Alessi, M., & Raoult, D. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.10.004 · Cited by 86
“ingluviei, which was accompanied by an increased expression of key lipogenic markers, such as FAS and SREBP1c, which have been implicated in the development of steatosis [16], and TNF, which is a proinflammatory cytokine that is known to initiate the early stages of fatty liver [19,20].”
BackgroundThe Influence of Light on Reactive Oxygen Species and NF-кB in Disease Progression
Rajendran, N. K., George, B. P. A., Chandran, R., Tynga, I. M., Houreld, N. N., & Abrahamse, H. (2019) · Antioxidants · doi:10.3390/antiox8120640 · Cited by 84
“Similarly, inflammation-induced hyperglycemia can be inhibited using specific inhibitors of interleukin-1 signaling [96].”
BackgroundMacrophages in homeostatic immune function
Jantsch, J., Binger, K. J., Müller, D. N., & Titze, J. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00146 · Cited by 89
“…linked to macrophage function, where the infiltration of macrophages into adipose tissue and their modulation of the inflammation level of this tissue greatly contributes to the development of insulin resistance (Arkan et al., 2005; Kanda et al., 2006; Weisberg et al., 2006; Lumeng et al., 2007b).”
BackgroundAcierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 73
Alterations in peripheral blood lymphocyte cytokine expression in obesity
O'Rourke, R. W., Kay, T., Lyle, E. A., Traxler, S. A., Deveney, C. W., Jobe, B. A., Roberts, C. T., Marks, D., & Rosenbaum, J. T. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03186.x · Cited by 77
Erridge, C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.043 · Cited by 87
Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology
Yudkin, J. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0711-3 · Cited by 75
Li, H., Yoon, J.-H., Won, H.-J., Ji, H.-S., Yuk, H. J., Park, K. H., Park, H.-Y., & Jeong, T. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.01.033 · Cited by 80
Ferrao, R., Li, J., Bergamin, E., & Wu, H. (2012) · Science Signaling · doi:10.1126/scisignal.2003124 · Cited by 84
Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
Oates, J. R., McKell, M. C., Moreno-Fernandez, M. E., Damen, M. S. M. A., Deepe, G. S., Qualls, J. E., & Divanovic, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02893 · Cited by 73
IKKβ links vascular inflammation to obesity and atherosclerosis
Sui, Y., Park, S., Xu, J., Monette, S., Helsley, R. N., Han, S., & Zhou, C. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131281 · Cited by 77
“Activation of NFB in multiple tissues including liver, adi pose tissue, and brain has been implicated in dietinduced obe sity and metabolic disorders (Yuan et al., 2001; Arkan et al., 2005; Cai et al., 2005; Zhang et al., 2008; Chiang et al., 2009).”
BackgroundPark, E., Wong, V., Guan, X., Oprescu, A. I., & Giacca, A. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0005 · Cited by 75
Wang, N., Ma, Y., Liu, Z., Liu, L., Yang, K., Wei, Y., Liu, Y., Chen, X., Sun, X., & Wen, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.07.002 · Cited by 82
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 70
Kang, S., Tsai, L. T., Zhou, Y., Evertts, A., Xu, S., Griffin, M. J., Issner, R., Whitton, H. J., Garcia, B. A., Epstein, C. B., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3080 · Cited by 77
IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance
Hung (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000065 · Cited by 75
Early Hepatic Insulin Resistance in Mice: A Metabolomics Analysis
Li, L. O., Hu, Y.-F., Wang, L. H.-C., Mitchell, M. W., Berger, A., & Coleman, R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0152 · Cited by 77
Social-Biological Interactions in Oral Disease: A ‘Cells to Society’ View
Gomaa, N. A., Glogauer, M., Tenenbaum, H. C., Siddiqi, A., & Quiñonez, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146218 · Cited by 85
Exercise and Adipose Tissue Macrophages: New Frontiers in Obesity Research?
Goh, J., Goh, K. P., & Abbasi, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00065 · Cited by 102
Miyachi, Y., Tsuchiya, K., Komiya, C., Shiba, K., Shimazu, N., Yamaguchi, S., Deushi, M., Osaka, M., Inoue, K., Sato, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.039 · Cited by 73
Silymarin is an ally against insulin resistance: A review
MacDonald-Ramos, K., Michán, L., Martínez‐Ibarra, A., & Cerbón, M. A. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.08.072 · Cited by 76
Ely, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., Needham, K. W., Comrada, L. N., & Minson, C. T. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2018 · Cited by 84
Liu, H.-Y., Collins, Q. F., Xiong, Y., Moukdar, F., Lupo, E. G., Liu, Z., & Cao, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609701200 · Cited by 72
Shi, S. Y., García-Martín, R., Duncan, R. E., Choi, D., Lu, S.-Y., Schroer, S. A., Cai, E. P., Luk, C. T., Hopperton, K. E., Domenichiello, A. F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.317453 · Cited by 76
“On the other hand, recent data suggest that steatosis and insulin resistance may be two separate manifestations of the metabolic disturbances in response to nutritional overload (33).”
BackgroundCarvalho-Filho, M. A., Carvalho, B. M., Oliveira, A. G., Guadagnini, D., Ueno, M., Dias, M. M., Tsukumo, D. M., Hirabara, S. M., Reis, L. F., Curi, R., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1400 · Cited by 72
Kurosaki, M., Hosokawa, T., Matsunaga, K., Hirayama, I., Tanaka, T., Sato, M., Yasui, Y., Tamaki, N., Ueda, K., Tsuchiya, K., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00692.x · Cited by 73
Weng, Y.-C., Chuang, S.-T., Lin, Y.-C., Chuang, C.-F., Chi, T.-C., Chiu, H., Kuo, Y., & Su, M. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/984780 · Cited by 71
“Hepatic NFκB signaling is activated by high-fat and high-fructose diet exposure and triggers insulin resistance [38], thereby linking inflammation with obesity-induced insulin resistance [39].”
BackgroundMitochondria as target of endocrine-disrupting chemicals: implications for type 2 diabetes
Marroquí, L., Tudurí, E., Alonso‐Magdalena, P., Quesada, I., Nadal, Á., & dos Santos, R. S. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0362 · Cited by 78
Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease
Evans, L. W., Stratton, M. S., & Ferguson, B. S. (2020) · Natural Product Reports · doi:10.1039/c9np00057g · Cited by 74
Molecular mechanisms of insulin resistance in chronic hepatitis C
Douglas, M. W., & George, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4356 · Cited by 81
Purvis, G. S. D., Collino, M., Aranda-Tavío, H., Chiazza, F., O’Riordan, C. E., Zeboudj, L., Mohammad, S., Collotta, D., Verta, R., Guisot, N. E. S., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15182 · Cited by 76
Regidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010384 · Cited by 77
The metabolic effects of growth hormone in adipose tissue
Chaves, V. E., Júnior, F. M., & Bertolini, G. L. (2013) · Endocrine · doi:10.1007/s12020-013-9904-3 · Cited by 79
“increased subcutaneous fat in the thighs and hips entails little or no risk of metabolic disease [85–87].”
BackgroundHepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S., & Serlie, M. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2157-x · Cited by 69
Sun, X., Feng, R., Li, Y., Lin, S., Zhang, W., Li, Y., Sun, C., & Li, S. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001056 · Cited by 72
Bhatt, B. A., Dube, J. J., Dedousis, N., Reider, J. A., & O’Doherty, R. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00097.2005 · Cited by 69
Central Regulation of Glucose Homeostasis
Tups, A., Benzler, J., Sergi, D., Ladyman, S. R., & Williams, L. M. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160015 · Cited by 63
The protective effects of Chinese yam polysaccharide against obesity-induced insulin resistance
Cheng, Z., Hu, M., Tao, J., Yang, H., Yan, P., An, G., & Wang, H. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.02.023 · Cited by 69
Yu, Y., Cai, Z., Zheng, J., Chen, J., Zhang, X., Huang, X., & Li, D. (2012) · Nutrition Research · doi:10.1016/j.nutres.2011.12.004 · Cited by 74
Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies
Morwick, T. M., Berry, A. K., Brickwood, J. R., Cardozo, M. G., Catron, K. M., DeTuri, M., Emeigh, J., Homon, C. A., Hrapchak, M. J., Jacober, S. P., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0510979 · Cited by 68
Impact of liver diseases on the development of type 2 diabetes mellitus
Hsieh, P., & Hsieh, Y.-J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i48.5240 · Cited by 71
The PGC-1 coactivators promote an anti-inflammatory environment in skeletal muscle in vivo
Eisele, P. S., Furrer, R., Beer, M., & Handschin, C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.166 · Cited by 68
“For example, a metabolic imbalance in obesity not only leads to metabolic dysregulation, but also a chronic systemic inflammation [1,2,3].”
BackgroundCellular inflammatory responses: Novel insights for obesity and insulin resistance
Chen, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.003 · Cited by 82
Overman, A., Bumrungpert, A., Kennedy, A. J., Martinez, K., Chuang, C.-C., West, T., Dawson, B., Jia, W. P., & McIntosh, M. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.296 · Cited by 81
Chai, W., & Liu, Z. (2007) · Endocrinology · doi:10.1210/en.2006-1068 · Cited by 67
Molecular biology for formyl peptide receptors in human diseases
Li, Y., & Ye, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1005-5 · Cited by 71
G protein–coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice
Osborn, O., Oh, D. Y., McNelis, J., Sanchez-Alavez, M., Talukdar, S., Lu, M., Li, P., Thiede, L., Morinaga, H., Kim, J. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61953 · Cited by 67
Self-citationAhmad, S. B., Rehman, M. U., Amin, I., Mir, M. R., Ahmad, S. B., Farooq, A., Bashir, S. M., Hussain, I., Masoodi, M. H., & Fatima, B. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.07.001 · Cited by 66
“Previous studies have demonstrated the significant role of NF-jB in pathogenesis of diabetes (Arkan et al 2005; Cai et al., 2005).”
BackgroundActivated Kupffer cells inhibit insulin sensitivity in obese mice
Tencerova, M., Aouadi, M., Vangala, P., Nicoloro, S. M., Yawe, J. C., Cohen, J. L., Shen, Y., Garcia‐Menendez, L., Pedersen, D. J., Gallagher‐Dorval, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-270496 · Cited by 65
Turning off the inflammatory, but not the metabolic, flames
Calay, E. S., & Hotamışlıgil, G. S. (2013) · Nature Medicine · doi:10.1038/nm.3114 · Cited by 75
Bumrungpert, A., Kalpravidh, R. W., Chitchumroonchokchai, C., Chuang, C., West, T., Kennedy, A. J., & McIntosh, M. (2009) · Journal of Nutrition · doi:10.3945/jn.109.106617 · Cited by 76
Small-Molecule Inhibitors of PKR Improve Glucose Homeostasis in Obese Diabetic Mice
Nakamura, T., Arduini, A., Baccaro, B., Furuhashi, M., & Hotamışlıgil, G. S. (2013) · Diabetes · doi:10.2337/db13-1019 · Cited by 71
Henriquez-Olguin, C., Meneses-Valdes, R., & Jensen, T. E. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101473 · Cited by 64
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Sancar, G., & Birkenfeld, A. L. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0115 · Cited by 80
Sottero, B., Gargiulo, S., Russo, I., Barale, C., Poli, G., & Cavalot, F. L. (2015) · Medicinal Research Reviews · doi:10.1002/med.21349 · Cited by 85
Self-citationBarazzoni, R., Zhu, X., DeBoer, M. D., Datta, R., Culler, M. D., Zanetti, M., Guarnieri, G., & Marks, D. L. (2009) · Kidney International · doi:10.1038/ki.2009.411 · Cited by 69
Lactobacillus plantarum OLL2712 Regulates Glucose Metabolism in C57BL/6 Mice Fed a High-Fat Diet
SAKAI, T., TAKI, T., NAKAMOTO, A., SHUTO, E., TSUTSUMI, R., TOSHIMITSU, T., MAKINO, S., & IKEGAMI, S. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.144 · Cited by 64
Li, R., Xu, X., Chen, C., Wang, Y., Gruzdev, A., Zeldin, D. C., & Wang, D. W. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00118.2014 · Cited by 69
Hill, A. A., Anderson‐Baucum, E. K., Kennedy, A. J., Webb, C. D., Yull, F. E., & Hasty, A. H. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.005 · Cited by 76
de Mello, V. D., Kolehmainen, M., Pulkkinen, L., Schwab, U., Mager, U., Laaksonen, D. E., NISKANEN, L. K., Gylling, H., Atalay, M., Rauramaa, R., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1132-7 · Cited by 68
Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity
Zhao, L., Fu, Z., Wu, J., Aylor, K. W., Barrett, E. J., Cao, W., & Liu, Z. (2015) · Clinical Science · doi:10.1042/cs20150143 · Cited by 63
Li, X., McGrath, K. C. Y., Nammi, S., Heather, A. K., & Roufogalis, B. D. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00791.x · Cited by 74
Tsai, C., Liu, K., Lin, Y., & Kuo, W. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300356 · Cited by 73
Lee, J.-T., Pamir, N., Liu, N.-C., Kirk, E. A., Averill, M. M., Becker, L., Larson, I. A., Hagman, D. K., Foster‐Schubert, K. E., Yserloo, B. V., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1037 · Cited by 75
Steatosis and NASH in type 2 diabetes
Hu, M., Phan, F., Bourron, O., Ferré, P., & Foufelle, F. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.019 · Cited by 68
Animal models of NAFLD from the pathologist's point of view
Denk, H., Abuja, P. M., & Zatloukal, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.024 · Cited by 70
Ge, C., Xu, M., Qin, Y., Gu, T.-T., Feng, J., Jinxiao, L., Sujun, W., Ma, Y., Deshuai, L., Qiang, L., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.034 · Cited by 65
Chuang, C., Bumrungpert, A., Kennedy, A. J., Overman, A., West, T., Dawson, B., & McIntosh, M. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.002 · Cited by 70
Nallasamy, P., Kannappan, S., & Anuradha, C. V. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.011 · Cited by 67
The Multifaceted Haptoglobin in the Context of Adipose Tissue and Metabolism
Maffei, M., Barone, I., Scabia, G., & Santini, F. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1009 · Cited by 68
Nutritional approaches for managing obesity-associated metabolic diseases
Botchlett, R. E., Woo, S., Liu, M., Pei, Y., Guo, X., Li, H., & Wu, C. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0580 · Cited by 72
Zhao, Y., Wang, F., Gao, L., Xu, L., Tong, R., Lin, N., Su, Y., Yang, Y., Gao, Y., He, J., et al. (2018) · Hepatology · doi:10.1002/hep.29889 · Cited by 64
Diet, obesity and diabetes: a current update
Walker, C. G., Zariwala, M. G., Holness, M. J., & SUGDEN, M. C. (2007) · Clinical Science · doi:10.1042/cs20060150 · Cited by 66
Metadata
- Authors
- Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Moffitt Cancer Center (US)
- Ospedale San Luigi Gonzaga (IT)
- Corresponding author
- Olefsky, Jerrold
- Karin, Michael
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-01-30
- Volume
- 11
- Issue
- 2
- Pages
- 191-198
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1991401793
- Cited by
- 1,773
- References
- 42
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 47 · 2023: 50 · 2022: 64 · 2021: 54 · 2020: 74 · 2019: 77 · 2018: 83 · 2017: 69 · 2016: 82 · 2015: 100 · 2014: 113 · 2013: 129 · 2012: 123
- FWCI
- 67.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- National Institutes of Health
- University of California, San Diego
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 60484, DK-33651, K01DK060484)
- National Institute of Environmental Health Sciences (ES 06376, R01ES006376)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- IKKβ, insulin resistance, obesity, inflammation, NF-κB, type 2 diabetes, hepatic insulin resistance, myeloid cells, high-fat diet, aging, skeletal muscle insulin sensitivity, adipose tissue insulin sensitivity
- MeSH terms
- Animals, Cells, Cultured, Dietary Fats, Glucose Tolerance Test, Inflammation, Insulin, Insulin Resistance, Obesity, Phenotype, Signal Transduction, Cytokines, NF-kappa B, Protein Serine-Threonine Kinases, Mice, Knockout, Myeloid Cells, Hepatocytes, Mice, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.